ZNTL - Balance Sheet - Zentalis Pharmaceuticals, Inc.

Current Liabilities	52.7 M
Accounts Payable	7.44 M
Short-Term Debt	0
Other Current Liabilities	45.3 M
Non-Current Liabilities	40.4 M
Long-Term Debt	0
Other Non-Current Liabilities	40.4 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	33.9	28.0	43.1	59.7	55.0	82.4	25.2
Short Term Investments	337.2	454.9	394.3	280.2	283.6	0	0
Receivables	5.0	0	0	2.6	0.4	0.1	0.9
Inventory	0	0	(7.0)	(4.4)	0	0	0
Other Current Assets	10.0	13.8	29.1	8.0	11.2	1.5	0.6
Total Current Assets	386.1	496.7	451.9	350.8	345.1	84.1	26.7
PP&E	37.2	41.7	50.1	52.8	3.6	2.8	0.3
Intangible Assets	0	0	0	0	8.8	8.8	8.8
Goodwill	0	3.7	3.7	3.7	3.7	3.7	3.7
Long Term Investments	0	0	21.2	37.5	1.3	0.2	46.3 K
Other Long Term Assets	7.0	9.5	(1.8)	2.6	2.3	2.2	1.5
Other Assets	0	0	0	0	0	0	0
Total Assets	430.3	551.7	539.3	454.5	365.6	102.7	41.0
LIABILITIES
Accounts Payable	7.4	14.9	11.2	11.6	8.7	4.3	3.4
Short Term Debt	0	0	0	1.5	0.9	0.8	0
Other Current Liabilities	45.3	54.2	45.4	29.9	18.6	9.8	2.8
Total Current Liabilities	52.7	69.4	56.6	43.9	28.6	14.9	6.2
Long Term Debt	0	43.1	90.3	88.9	1.1	0	0
Deferred Tax Income	0	0	0.9	1.6	2.5	2.5	2.5
Other Liabilities	40.4	1.8	(42.5)	(44.5)	0	0.9	21 K
Total Liabilities	93.2	114.3	105.3	90.0	32.2	19.1	8.7
EQUITY
Common Stock	71 K	70 K	59 K	45 K	41 K	25 K	2.3
Retained Earnings	(1 054.4)	(888.6)	(596.4)	(359.6)	(200.8)	(83.0)	(37.3)
Other Accumulative Comprehensive Income/Loss	0.6	2.2	(1.4)	(0.1)	36 K	(141.7)	56 K
Total Equity	337.2	437.4	434.2	365.0	358.2	83.6	32.3
Total Liabilities and Equity	430.3	551.7	539.3	454.5	365.6	102.7	41.0
SHARES OUTSTANDING
Common Shares Outstanding	71.1	65.4	52.9	42.7	41.0	35.9	18.1

Free